0001655759-24-000004.txt : 20240108 0001655759-24-000004.hdr.sgml : 20240108 20240108163950 ACCESSION NUMBER: 0001655759-24-000004 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240104 FILED AS OF DATE: 20240108 DATE AS OF CHANGE: 20240108 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Taylor Ian CENTRAL INDEX KEY: 0001753281 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38672 FILM NUMBER: 24520701 MAIL ADDRESS: STREET 1: C/O ARVINAS, INC., 5 SCIENCE PARK STREET 2: 395 WINCHESTER AVENUE CITY: NEW HAVEN STATE: CT ZIP: 0651 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ARVINAS, INC. CENTRAL INDEX KEY: 0001655759 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 472566120 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 395 WINCHESTER AVE STREET 2: 5 SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 BUSINESS PHONE: 203-535-1456 MAIL ADDRESS: STREET 1: 395 WINCHESTER AVE STREET 2: 5 SCIENCE PARK CITY: NEW HAVEN STATE: CT ZIP: 06511 FORMER COMPANY: FORMER CONFORMED NAME: ARVINAS INC. DATE OF NAME CHANGE: 20181001 FORMER COMPANY: FORMER CONFORMED NAME: ARVINAS HOLDING COMPANY, LLC DATE OF NAME CHANGE: 20151015 4 1 wk-form4_1704749977.xml FORM 4 X0508 4 2024-01-04 0 0001655759 ARVINAS, INC. ARVN 0001753281 Taylor Ian C/O ARVINAS, INC. 5 SCIENCE PARK, 395 WINCHESTER AVE. NEW HAVEN CT 06511 0 1 0 0 Chief Scientific Officer 0 Common Stock 2024-01-04 4 M 0 8252 16 A 109973 D Stock Option (right to buy) 16 2024-01-04 4 M 0 0 0 D 2028-09-25 Common Stock 3353 10519 D Stock Option (right to buy) 16 2024-01-04 4 M 0 0 0 D 2028-09-25 Common Stock 4899 2065 D This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of June 28, 2019, and the remainder of the shares vested in equal monthly installments following June 28, 2019 through June 28, 2022. This option award was granted on September 26, 2018. 1/4 of the shares underlying the award vested as of March 31, 2019, and the remainder of the shares vested in equal monthly installments following March 31, 2019 through March 31, 2022. /s/ John Houston, as attorney-in-fact for Ian Taylor 2024-01-08